For Sales
From
Description
FACTA® stands for Functional Antigen Cross-linking Targeting Alpha-Gal, the technology developed by BCI to improve the performance of all implantable bioprosthetic medical devices and animal-derived substrates used as support, construction and surgical repair materials.